Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · IEX Real-Time Price · USD
+0.60 (1.65%)
At close: May 24, 2024, 4:00 PM
-0.75 (-2.03%)
After-hours: May 24, 2024, 7:30 PM EDT

Celldex Therapeutics Revenue

Celldex Therapeutics had revenue of $6.07M in the twelve months ending March 31, 2024, with 92.76% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $156.00K, a -83.87% decrease year-over-year. In the year 2023, Celldex Therapeutics had annual revenue of $6.88M with 192.02% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
2.43B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20236.88M4.53M192.02%
Dec 31, 20222.36M-2.29M-49.32%
Dec 31, 20214.65M-2.77M-37.30%
Dec 31, 20207.42M3.85M107.61%
Dec 31, 20193.57M-5.97M-62.54%
Dec 31, 20189.54M-3.21M-25.15%
Dec 31, 201712.74M5.96M87.78%
Dec 31, 20166.79M1.31M23.83%
Dec 31, 20155.48M1.89M52.82%
Dec 31, 20143.59M-525.00K-12.77%
Dec 31, 20134.11M-7.09M-63.30%
Dec 31, 201211.20M1.94M20.91%
Dec 31, 20119.27M-37.53M-80.20%
Dec 31, 201046.79M31.61M208.25%
Dec 31, 200915.18M7.72M103.59%
Dec 31, 20087.46M6.05M430.30%
Dec 31, 20071.41M506.82K56.36%
Dec 31, 2006899.18K-2.19M-70.88%
Dec 31, 20053.09M-3.77M-54.97%
Dec 31, 20046.86M2.23M48.04%
Dec 31, 20034.63M-2.07M-30.90%
Dec 31, 20026.70M3.36M100.39%
Dec 31, 20013.35M2.58M338.40%
Dec 31, 2000763.20K-720.30K-48.55%
Dec 31, 19991.48M-666.90K-31.01%
Dec 31, 19982.15M958.30K80.39%
Dec 31, 19971.19M77.60K6.96%
Dec 31, 19961.11M-2.85M-71.88%
Dec 31, 19953.96M-3.00M-43.12%
Dec 31, 19946.97M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 4.78B
ICU Medical 2.26B
ACADIA Pharmaceuticals 813.81M
NovoCure 525.66M
Twist Bioscience 277.49M
RxSight 101.10M
Arvinas 71.30M
Intellia Therapeutics 52.60M
Revenue Rankings